​
​

Werewolf Therapeutics (HOWL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Werewolf Therapeutics Revenue Highlights

Latest Revenue (Y)

$19.94M

Latest Revenue (Q)

$1.14M

Werewolf Therapeutics Revenue by Period

Werewolf Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$19.94M21.60%
2022-12-31$16.40M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Werewolf Therapeutics generated $19.94M in revenue during NA 2023, up 21.60% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Werewolf Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$1.14M54.04%
2024-03-31$742.00K-50.57%
2023-12-31$1.50M-74.55%
2023-09-30$5.90M-27.03%
2023-06-30$8.08M81.03%
2023-03-31$4.46M-38.71%
2022-12-31$7.28M46.54%
2022-09-30$4.97M19.82%
2022-06-30$4.15M100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Werewolf Therapeutics generated $1.14M in revenue during Q2 2024, up 54.04% compared to the previous quarter, and up 25.60% compared to the same period a year ago.

Werewolf Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HOWLWerewolf Therapeutics$19.94M$1.14M
IKNAIkena Oncology$9.16M-
STOKStoke Therapeutics$8.78M$4.89M
MOLNMolecular Partners$7.04M$2.74M
MNOVMediciNova$1.00M-
ANEBAnebulo Pharmaceuticals--
DSGNDesign Therapeutics--
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
DBTXDecibel Therapeutics--
TALSTourmaline Bio--
ACETAdicet Bio--
CYTCyteir Therapeutics--
PASGPassage Bio--
ELYMEliem Therapeutics--
ACRVAcrivon Therapeutics--
CELCCelcuity--
VORVor Biopharma--
THRDThird Harmonic Bio--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
CSBRChampions Oncology--

HOWL Revenue FAQ

What is Werewolf Therapeutics’s yearly revenue?

Werewolf Therapeutics's yearly revenue for 2023 was $19.94M, representing an increase of 21.60% compared to 2022. The company's yearly revenue for 2022 was $16.4M, representing an increase of 100.00% compared to 2021. HOWL's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Werewolf Therapeutics’s quarterly revenue?

Werewolf Therapeutics's quarterly revenue for Q2 2024 was $1.14M, a 54.04% increase from the previous quarter (Q1 2024), and a -85.86% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $742K, a -50.57% decrease from the previous quarter (Q4 2023), and a -83.38% decrease year-over-year (Q1 2023). HOWL's quarterly revenue for Q4 2023 was $1.5M, a -74.55% decrease from the previous quarter (Q3 2023), and a -79.39% decrease year-over-year (Q4 2022).

What is Werewolf Therapeutics’s revenue growth rate?

Werewolf Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.